Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm.

Literature DB >> 17566035

One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm.

David Y Graham, Yoshio Yamaoka.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2007 PMID： 17566035 PMCID： PMC1994350 DOI： 10.1136/gut.2006.118109

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

19 in total

1. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.

Authors: X Calvet; N García; T López; J P Gisbert; E Gené; M Roque
Journal: Aliment Pharmacol Ther Date: 2000-05 Impact factor: 8.171

2. Furazolidone combination therapies for Helicobacter pylori infection in the United States.

Authors: D Y Graham; M S Osato; J Hoffman; A R Opekun; S Y Anderson; H M El-Zimaity
Journal: Aliment Pharmacol Ther Date: 2000-02 Impact factor: 8.171

3. cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia.

Authors: N Broutet; A Marais; H Lamouliatte; A de Mascarel; R Samoyeau; R Salamon; F Mégraud
Journal: J Clin Microbiol Date: 2001-04 Impact factor: 5.948

4. High eradication rates of Helicobacter pylori with a new sequential treatment.

Authors: A Zullo; D Vaira; N Vakil; C Hassan; L Gatta; C Ricci; V De Francesco; M Menegatti; A Tampieri; F Perna; V Rinaldi; F Perri; C Papadìa; F Fornari; S Pilati; L S Mete; A Merla; R Potì; G Marinone; A Savioli; S M A Campo; D Faleo; E Ierardi; M Miglioli; S Morini
Journal: Aliment Pharmacol Ther Date: 2003-03-01 Impact factor: 8.171

5. How can the current strategies for Helicobacter pylori eradication therapy be improved?

Authors: Alex Ford; Paul Moayyedi
Journal: Can J Gastroenterol Date: 2003-06 Impact factor: 3.522

6. Effectiveness of Helicobacter pylori eradication treatments in a primary care setting in Italy.

Authors: P Della Monica; A Lavagna; G Masoero; L Lombardo; L Crocellá; A Pera
Journal: Aliment Pharmacol Ther Date: 2002-07 Impact factor: 8.171

7. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.

Authors: V De Francesco; A Zullo; C Hassan; N Della Valle; L Pietrini; M F Minenna; S Winn; R Monno; V Stoppino; S Morini; C Panella; E Ierardi
Journal: Dig Liver Dis Date: 2004-05 Impact factor: 4.088

8. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.

Authors: Wieslaw J Bochenek; Suzanne Peters; Polly D Fraga; Wenjin Wang; Michael E Mack; Michael S Osato; Hala M T El-Zimaity; Kelly D Davis; David Y Graham
Journal: Helicobacter Date: 2003-12 Impact factor: 5.753

9. Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.

Authors: N Broutet; S Tchamgoué; E Pereira; H Lamouliatte; R Salamon; F Mégraud
Journal: Aliment Pharmacol Ther Date: 2003-01 Impact factor: 8.171

10. Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.

Authors: D Boixeda; C Martín De Argila; F Bermejo; A López Sanromán; F Hernández Ranz; A García Plaza
Journal: Rev Esp Enferm Dig Date: 2003-03 Impact factor: 2.086

3 in total